167 related articles for article (PubMed ID: 9868660)
1. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience.
Aronson NE; Wortmann GW; Johnson SC; Jackson JE; Gasser RA; Magill AJ; Endy TP; Coyne PE; Grogl M; Benson PM; Beard JS; Tally JD; Gambel JM; Kreutzer RD; Oster CN
Clin Infect Dis; 1998 Dec; 27(6):1457-64. PubMed ID: 9868660
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
[TBL] [Abstract][Full Text] [Related]
3. Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus.
Domingo P; Ferrer S; Kolle L; Muñoz C; Rodriguez P
Arch Intern Med; 1996 May; 156(9):1029, 1032. PubMed ID: 8624172
[No Abstract] [Full Text] [Related]
4. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases.
Thakur CP; Sinha GP; Pandey AK; Kumar N; Kumar P; Hassan SM; Narain S; Roy RK
Ann Trop Med Parasitol; 1998 Jul; 92(5):561-9. PubMed ID: 9797829
[TBL] [Abstract][Full Text] [Related]
5. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
7. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
[TBL] [Abstract][Full Text] [Related]
8. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
Ritmeijer K; Dejenie A; Assefa Y; Hundie TB; Mesure J; Boots G; den Boer M; Davidson RN
Clin Infect Dis; 2006 Aug; 43(3):357-64. PubMed ID: 16804852
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection.
Aronson NE; Wortmann GW; Byrne WR; Howard RS; Bernstein WB; Marovich MA; Polhemus ME; Yoon IK; Hummer KA; Gasser RA; Oster CN; Benson PM
PLoS Negl Trop Dis; 2010 Mar; 4(3):e628. PubMed ID: 20231896
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis.
Wortmann GW; Aronson NE; Byrd JC; Grever MR; Oster CN
Clin Infect Dis; 1998 Sep; 27(3):509-12. PubMed ID: 9770149
[TBL] [Abstract][Full Text] [Related]
11. Sodium stibogluconate.
Shrestha NK
Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
[No Abstract] [Full Text] [Related]
12. Experience with New World cutaneous leishmaniasis in travelers.
Scope A; Trau H; Anders G; Barzilai A; Confino Y; Schwartz E
J Am Acad Dermatol; 2003 Oct; 49(4):672-8. PubMed ID: 14512915
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
Ranawaka RR; Weerakoon HS
J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
[TBL] [Abstract][Full Text] [Related]
14. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis.
Hartzell JD; Aronson N
N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214
[No Abstract] [Full Text] [Related]
15. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
Bermúdez H; Rojas E; Garcia L; Desjeux P; Dujardin JC; Boelaert M; Chappuis F
Ann Trop Med Parasitol; 2006 Oct; 100(7):591-600. PubMed ID: 16989685
[TBL] [Abstract][Full Text] [Related]
16. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
Hepburn NC; Tidman MJ; Hunter JA
Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
[TBL] [Abstract][Full Text] [Related]
17. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline.
Rijal S; Chappuis F; Singh R; Bovier PA; Acharya P; Karki BM; Das ML; Desjeux P; Loutan L; Koirala S
Trans R Soc Trop Med Hyg; 2003; 97(3):350-4. PubMed ID: 15228258
[TBL] [Abstract][Full Text] [Related]
18. Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
Musa A; Khalil E; Hailu A; Olobo J; Balasegaram M; Omollo R; Edwards T; Rashid J; Mbui J; Musa B; Abuzaid AA; Ahmed O; Fadlalla A; El-Hassan A; Mueller M; Mucee G; Njoroge S; Manduku V; Mutuma G; Apadet L; Lodenyo H; Mutea D; Kirigi G; Yifru S; Mengistu G; Hurissa Z; Hailu W; Weldegebreal T; Tafes H; Mekonnen Y; Makonnen E; Ndegwa S; Sagaki P; Kimutai R; Kesusu J; Owiti R; Ellis S; Wasunna M
PLoS Negl Trop Dis; 2012; 6(6):e1674. PubMed ID: 22724029
[TBL] [Abstract][Full Text] [Related]
19. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Bourée P; Anciaux ML; Taugourdeau P
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
[TBL] [Abstract][Full Text] [Related]
20. New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate.
Lawn SD; Yardley V; Vega-Lopez F; Watson J; Lockwood DN
Trans R Soc Trop Med Hyg; 2003; 97(4):443-5. PubMed ID: 15259478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
